Follow
Ian R. Marsh
Title
Cited by
Cited by
Year
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade
RB Patel, R Hernandez, P Carlson, J Grudzinski, AM Bates, ...
Science translational medicine 13 (602), eabb3631, 2021
1092021
Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy
JC Jagodinsky, WJ Jin, AM Bates, R Hernandez, JJ Grudzinski, IR Marsh, ...
Theranostics 11 (13), 6120, 2021
422021
Direct reaction measurements using GODDESS
SD Pain, A Ratkiewicz, T Baugher, M Febbraro, A Lepailleur, ...
Physics Procedia 90, 455-462, 2017
292017
Preclinical characterization of 86/90Y-NM600 in a variety of murine and human cancer tumor models
JJ Grudzinski, R Hernandez, I Marsh, RB Patel, E Aluicio-Sarduy, J Engle, ...
Journal of Nuclear Medicine 60 (11), 1622-1628, 2019
252019
Preclinical pharmacokinetics and dosimetry studies of 124I/131I-CLR1404 for treatment of pediatric solid tumors in murine xenograft models
IR Marsh, J Grudzinski, DC Baiu, A Besemer, R Hernandez, JJ Jeffery, ...
Journal of Nuclear Medicine 60 (10), 1414-1420, 2019
252019
Targeted molecular radiotherapy of pediatric solid tumors using a radioiodinated alkyl-phospholipid ether analog
DC Baiu, IR Marsh, AE Boruch, A Shahi, S Bhattacharya, JJ Jeffery, ...
Journal of Nuclear Medicine 59 (2), 244-250, 2018
212018
CLR 125 Auger electrons for the targeted radiotherapy of triple-negative breast cancer
J Grudzinski, I Marsh, B Titz, J Jeffery, M Longino, K Kozak, K Lange, ...
Cancer Biotherapy & Radiopharmaceuticals 33 (3), 87-95, 2018
182018
Murine-specific internal dosimetry for preclinical investigations of imaging and therapeutic agents
B Bednarz, J Grudzinski, I Marsh, A Besemer, D Baiu, J Weichert, M Otto
Health physics 114 (4), 450-459, 2018
182018
Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative …
K Magee, IR Marsh, MM Turek, J Grudzinski, E Aluicio-Sarduy, JW Engle, ...
PLoS One 16 (8), e0255798, 2021
172021
Collectivity of states in
SR Lesher, C Casarella, A Aprahamian, BP Crider, R Ikeyama, IR Marsh, ...
Physical Review C 91 (5), 054317, 2015
122015
Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors
HK Potluri, CA Ferreira, J Grudzinski, C Massey, E Aluicio-Sarduy, ...
Journal for Immunotherapy of Cancer 10 (8), 2022
112022
Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the Brain
PA Clark, RN Sriramaneni, AM Bates, WJ Jin, JC Jagodinsky, ...
Radiation research 195 (6), 522-540, 2021
112021
Lifetime measurements of low-spin negative-parity levels in
SR Lesher, C Casarella, A Aprahamian, LM Robledo, BP Crider, ...
Physical Review C 95 (6), 064309, 2017
112017
Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination
PM Carlson, RB Patel, J Birstler, M Rodriquez, C Sun, AK Erbe, AM Bates, ...
Journal for Immunotherapy of Cancer 11 (1), 2023
32023
Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry
IR Marsh, C Li, J Grudzinski, J Jeffery, C Longhurst, DP Adam, ...
Cancer Biotherapy & Radiopharmaceuticals 38 (7), 458-467, 2023
12023
Inelastic Neutron Scattering on 160Gd
SR Lesher, C Casarella, BP Crider, R Ikeyama, I Marsh, EE Peters, ...
EPJ Web of Conferences 66, 02063, 2014
12014
Treatment Planning for Immunomodulatory Radiopharmaceutical Therapy
IR Marsh
The University of Wisconsin-Madison, 2021
2021
Transfer Reactions with 134Xe
SD Pain, KA Chipps, M Febbraro, I Marsh, MS Smith, RL Varner, ...
Fission and Properties of Neutron-Rich Nuclei: Proceedings of the Sixth …, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–18